Stocks and Investing Stocks and Investing
Wed, October 24, 2018
Tue, October 23, 2018
Mon, October 22, 2018

Reni Benjamin Maintained (ADAP) at Buy with Decreased Target to $16 on, Oct 22nd, 2018


Published on 2024-10-26 09:45:33 - WOPRAI, Reni Benjamin
  Print publication without navigation


Reni Benjamin of Raymond James, Maintained "Adaptimmune Therapeutics plc" (ADAP) at Buy with Decreased Target from $20 to $16 on, Oct 22nd, 2018.

Reni, nor any peers, have made any analyst calls on ADAP in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30

Contributing Sources